What is Hisamitsu Pharmaceutical Co EV-to-Revenue?
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hisamitsu Pharmaceutical Co's enterprise value is 円166,345 Mil.
Hisamitsu Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Nov. 2023 was 円141,706 Mil. Therefore, Hisamitsu Pharmaceutical Co's EV-to-Revenue for today is 1.17.
The historical rank and industry rank for Hisamitsu Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:
TSE:4530'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.94 Med: 2.05 Max: 4.86
Current: 1.17
During the past 13 years, the highest EV-to-Revenue of Hisamitsu Pharmaceutical Co was 4.86. The lowest was 0.94. And the median was 2.05.
TSE:4530's EV-to-Revenue is ranked better than 75.56% of 1027
companies
in the Drug Manufacturers industry
Industry Median: 2.41
vs TSE:4530: 1.17
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hisamitsu Pharmaceutical Co's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hisamitsu Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Hisamitsu Pharmaceutical Co's EV-to-Revenue falls into.
Hisamitsu Pharmaceutical Co EV-to-Revenue Calculation
Hisamitsu Pharmaceutical Co's current Enterprise Value is 円166,345 Mil.
Hisamitsu Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円141,706 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hisamitsu Pharmaceutical Co (TSE:4530) EV-to-Revenue Explanation
Hisamitsu Pharmaceutical Co's share price for today is 円3823.00.
Hisamitsu Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,842.36.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hisamitsu Pharmaceutical Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Hisamitsu Pharmaceutical Co (TSE:4530) Business Description
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4530 has been successfully added to your 